Drug Houses of Australia
| Type |
|
|---|---|
| Industry | Pharmaceutical manufacture |
| Predecessors |
|
| Founded | 1936 in Australia |
| Founders |
|
| Fate | Takeover; subsequent trade sale |
| Successor | Slater Walker (1970) |
| Parent | Strides Arcolab (since 2006) |
Drug Houses of Australia was an Australian public company established in 1936 as an amalgamation of seven Australian pharmaceutical companies, including Felton Grimwade & Co and A. M. Bickford & Sons. In 1970, DHA was taken over by the British bank Slater Walker.[1][2][3]
In September 2006, the Australian company was sold to Strides Arcolab through a share purchase agreement with Haw Par Healthcare Limited, Singapore, for approximately SGD$19.7 million. Drug Houses of Australia (Asia) Pte Ltd is now a leading manufacturer of generic pharmaceutics and Chinese proprietary medicine (CPM) based in Jurong, Singapore; and is a subsidiary of Strides Arcolab that is listed on both the Bombay and National stock exchanges in India.
References
- ↑ "Bickford's". SA Memory, State Library of South Australia.
- ↑ Poynter, J. R. (2006) [1983]. "Grimwade, Edward Norton (1866–1945)". Australian Dictionary of Biography. Vol. 9. National Centre of Biography, Australian National University. ISBN 978-0-522-84459-7. ISSN 1833-7538. OCLC 70677943. Retrieved 12 August 2026.
- ↑ Poynter, J. R. (2006) [1996]. "Grimwade, Geoffrey Holt (1902–1961)". Australian Dictionary of Biography. Vol. 14. National Centre of Biography, Australian National University. ISBN 978-0-522-84459-7. ISSN 1833-7538. OCLC 70677943. Retrieved 12 August 2026.
External links
- "Home page". Drug Houses of Australia (Asia) Pte Ltd. Singapore. Archived from the original on 5 December 2006.
- Strides Arcolab website
- Haw Par website